Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Differin is equieffective but better tolerated than Retin A in patients with acne

Oct. 29, 1997

Apligraf comparable to autograft for donor site wounds

Oct. 29, 1997

VIMRxyn enters phase II for treatment of skin diseases

Oct. 27, 1997

Topical antiinflammatory activity of COX-2 inhibitors assessed

Oct. 27, 1997

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

ADCON-L up for advisory committee review

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...